Micropapillary carcinoma
|
disease |
|
Neoplastic Process
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Neoplasm of uncertain or unknown behavior of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
29
|
|
0.300 |
None |
|
0 |
|
|
|
Metastatic Lung Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
34
|
10
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Invasive Prostate Carcinoma
|
disease |
|
Neoplastic Process
|
45
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metastatic osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
51
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
stage, ovarian epithelial cancer
|
disease |
|
Neoplastic Process
|
65
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Leishmaniasis, Visceral
|
disease |
Infections
|
Disease or Syndrome
|
197
|
22
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Anaplastic thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
392
|
16
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
3 |
4
|
2017 |
2019 |
Corpuscular Hemoglobin Concentration Mean
|
phenotype |
|
Laboratory or Test Result
|
401
|
4389
|
0.100 |
None |
1.000 |
1 |
18
|
2012 |
2012 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
478
|
667
|
0.100 |
None |
1.000 |
1 |
3
|
2011 |
2011 |
Ewings sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
25
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Ovarian Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
539
|
19
|
0.330 |
None |
1.000 |
3 |
|
2015 |
2016 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.300 |
None |
|
0 |
|
|
|
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Microcephaly
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Congenital Abnormality
|
1064
|
27
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |